Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $595K 11.6K sh |
| Nov 4, 2026 traded Nov 4, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $612K 12.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $998K 21.4K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 14 | Jampol ThadChief Product Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $210K 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Anderson RaymondDirector |  MNPRMonopar TherapeuticsOpen-market sale · 10b5-1 plan | SELL | $40K 600 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $68K 2,257 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $3,494 9 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO |  VRSNVERISIGN INC/CAOpen-market sale · 10b5-1 plan | SELL | $119K 380 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Sheena JonathanDirector, CO-FOUNDER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 109 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Sheena JonathanDirector, CO-FOUNDER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $1,165 3 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Wampler Kira SchererDirector |  DOCSDoximity, Inc.Open-market sale · 10b5-1 plan | SELL | $66K 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Raabe Kyle AndrewPresident, Home Power Gen. |  GNRCGENERAC HOLDINGS INC.Open-market sale · 10b5-1 plan | SELL | $81K 386 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Sine Jared F.Chief Strategy & Legal Officer |  GDDYGoDaddy Inc.Open-market sale · 10b5-1 plan | SELL | $118K 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | VRSNVERISIGN INC/CA Open-market sale · 10b5-1 plan | SELL | $201K 640 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | VRSNVERISIGN INC/CA Open-market sale · 10b5-1 plan | SELL | $202K 640 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | VRSNVERISIGN INC/CA Open-market sale · 10b5-1 plan | SELL | $63K 200 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Kasbar Michael JDirector, Executive Chairman |  WKCWORLD KINECT CORPOpen-market sale · 10b5-1 plan | SELL | $72K 1,938 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER |  IBTAIbotta, Inc.Open-market sale · 10b5-1 plan | SELL | $31K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $33K 80 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $35K 662 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $2,717 7 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $97K 700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $182K 1,326 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $6,599 17 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $3,104 8 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $240K 1,759 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $50K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $2,717 7 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $190K 1,374 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chapman Steven LeonardDirector, CEO AND PRESIDENT | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $8,146 21 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $846K 4,493 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $1.70M 4,846 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $3.48M 13.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Coghlan John PhilipDirector |  LIFLife360, Inc.Open-market sale · 10b5-1 plan | SELL | $83K 1,841 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $23K 208 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $29K 1,075 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Singh SumitDirector, Chief Executive Officer |  CHWYChewy, Inc.Open-market sale · 10b5-1 plan | SELL | $492K 23.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Coghlan John PhilipDirector | LIFLife360, Inc. Open-market sale · 10b5-1 plan | SELL | $66K 1,433 sh | Nov 4, 2026 traded Nov 2, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K